Sizing accuracy and intra-assay precision of DLS measurements with Prometheus Panta

November 13, 2020

Scientists in the field of drug discovery, particularly biologics, use DLS to make critical decisions about drug candidate stability. This creates a need for instruments that exhibit strong sizing accuracy and precision. These properties can be evaluated using standards and references from the National Institute of Standards and Technology (NIST). Here, the NIST monoclonal antibody (NISTmAb) reference material (RM) RM8671, Lysozyme, and a set of monodisperse particle size standards were used to test the sizing accuracy and intra-assay precision of Prometheus Panta’s DLS optical module.

Previous Video
The new gold standard in biologic characterization – Develop your biologics faster and better with Prometheus
The new gold standard in biologic characterization – Develop your biologics faster and better with Prometheus

Development of therapeutic antibodies is a long and costly process. One key indicator of whether biologic c...

Up next
Use of high-throughput methods for early stage formulation evaluation and their correlation to stability studies
Use of high-throughput methods for early stage formulation evaluation and their correlation to stability studies

AbbVie preformulation is an early discovery biologics group working to optimise antibodies prior to downstr...

Looking for the optimal formulation for your biologics candidates?

NanoTemper tools can help

Find out how